资讯日报-20250514

Market Overview - The Hong Kong stock market experienced a decline, with the Hang Seng Index falling by 1.87% to close at 23,108 points, while the Hang Seng Tech Index dropped by 3.26% [4][9] - The US stock market showed mixed results, with the Dow Jones decreasing by 0.64% and the Nasdaq increasing by 1.61% [9] - The Nikkei 225 index in Japan rose by 1.43%, reaching a new high of 38,183 points, amid easing trade tensions between the US and China [3][4] Sector Performance - Major technology stocks in Hong Kong faced significant losses, with Meituan and Kuaishou both dropping over 4%, and Alibaba and Xiaomi falling more than 3% [9] - In contrast, the biopharmaceutical sector saw a rebound, with companies like WuXi Biologics rising over 6% and other firms like Rongchang Bio and BeiGene increasing by more than 4% [9] - Gold stocks gained traction, with Tongguan Gold surging over 15% and other gold companies also seeing increases [9] Investment Outlook - Nomura Securities upgraded its rating on Chinese stocks to "tactical overweight" following the US-China trade negotiations, indicating a shift of funds from India to China [9] - Citigroup raised its year-end target for the Hang Seng Index by 2% to 25,000 points, predicting it could reach 26,000 points by mid-2026 [9] Company Highlights - JD.com reported better-than-expected Q1 results, with revenue of 301.1 billion yuan, a year-on-year increase of 15.8%, marking the highest growth rate in nearly three years [13] - The company also achieved an adjusted net profit of 12.8 billion yuan, up 43.4% year-on-year, exceeding market expectations [13]